Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Oxford Centre for Neuroinflammation

Oxford Centre for Neuroinflammation

Strategic Developments

We are delighted to announce the launch of the new Oxford Centre for Neuroinflammation (OCNI), which aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways

'Tapping the full potential of Europe's health data'

'Tapping the full potential of Europe's health data'

A focus on the EU and industry-funded EMIF project, co-coordinated by Professor Simon Lovestone, which has created a secure online platform consolidating metadata from a wide variety of sources.

Digital festival engages public with brain research

Digital festival engages public with brain research

Public Engagement

For Brain Awareness Week 2018, our Wellcome Centre for Integrative Neuroimaging got together with Oxford Sparks to present an immersive experience of some of Oxford's brain research.

New Chair in Emerging Technologies

New Chair in Emerging Technologies

Strategic Developments

The Royal Academy of Engineering has announced long-term support to ten engineering global visionaries to develop areas of emerging technology.

Professor Michael Gelder (1929 - 2018)

Professor Michael Gelder (1929 - 2018)

In Memoriam

A tribute to the founder of the University of Oxford's Department of Psychiatry.

All antidepressants are more effective than placebo at treating acute depression in adults, concludes study

All antidepressants are more effective than placebo at treating acute depression in adults, concludes study

Events

Meta-analysis led by Dr Andrea Cipriani (Department of Psychiatry) of 522 trials includes the largest amount of unpublished data to date, and finds that antidepressants are more effective than placebo for short-term treatment of acute depression in adults.

Load More +